N/A
N=4
A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients
Suicidal and Self-injurious Behavior
Bottom Line
View on ClinicalTrials.gov: NCT05486091 ↗Enrolled (actual)
4
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Client Satisfaction at Discharge — 29.00 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- App-Enhanced Brief Cognitive-Behavioral Therapy (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Hartford Hospital
- Primary completion
- Feb 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Client Satisfaction at Discharge |
29.00 | — |
| PRIMARY App Usability at Discharge |
95.00 | — |
| PRIMARY Frequency of Suicide Attempts |
— | — |
| PRIMARY Suicidal Ideation Baseline |
82.00 | — |
| PRIMARY Suicidal Ideation at Discharge |
46.67 | — |
| PRIMARY Suicidal Ideation 1 Month |
21.00 | — |
| PRIMARY Suicidal Ideation 2 Months |
25.00 | — |
| PRIMARY Suicidal Ideation 3 Months |
45.00 | — |
Summary
The purpose of this study is to evaluate the feasibility of integrating Brief Cognitive-Behavioral Therapy (BCBT) counseling with a software application (app) to prevent future suicidal thoughts and behaviors.
Eligibility Criteria
Inclusion Criteria
- History of suicide attempt (lifetime) AND active ideation (with or without plan or intent) on admission
- Own and have access to their phone (iPhone or Android with capability to download apps) during their inpatient stay
- Ability to understand the nature of the study and provide written informed consent
- Willing and able to provide at least two verifiable contacts for emergency or tracking purposes
- Expected length of stay long enough to complete the entire treatment protocol
Exclusion Criteria
- Not fluent in English
- Experiencing current mania or psychosis
- Have lifetime history of schizophrenia spectrum disorder, intellectual disability, or organic brain illness
- Inpatient treatment plan includes detox protocol or electroconvulsive therapy
- Any other psychiatric or medical condition that in the investigator's opinion would preclude informed consent or participation in the trial
Data sourced from ClinicalTrials.gov (NCT05486091). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.